IL97641A0 - Methods for treating interleukin-1 mediated diseases - Google Patents

Methods for treating interleukin-1 mediated diseases

Info

Publication number: IL97641A0
Authority: IL; Israel
Prior art keywords: methods; mediated diseases; treating interleukin; interleukin; treating
Prior art date: 1990-04-02

Application number

IL97641A

Original Assignee

Synergen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-04-02

Filing date

1991-03-21

Publication date

1992-06-21

1991-03-21 Application filed by Synergen Inc filed Critical Synergen Inc

1992-06-21 Publication of IL97641A0 publication Critical patent/IL97641A0/en

1998-10-29 Priority to IL12681998A priority Critical patent/IL126819A0/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IL97641A 1990-04-02 1991-03-21 Methods for treating interleukin-1 mediated diseases IL97641A0 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
IL12681998A IL126819A0 (en)	1990-04-02	1998-10-29	Use of interleukin-1 inhibitors for manufacture of medicaments for treatment or prevention of interleukin-1 mediated diseases

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US50274590A	1990-04-02	1990-04-02
US52421090A	1990-05-16	1990-05-16
US53055390A	1990-05-29	1990-05-29

Publications (1)

Publication Number	Publication Date
IL97641A0 true IL97641A0 (en)	1992-06-21

Family

ID=27414214

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL97641A IL97641A0 (en)	1990-04-02	1991-03-21	Methods for treating interleukin-1 mediated diseases

Country Status (5)

Country	Link
JP (3)	JP2609485B2 (en)
KR (1)	KR920005691A (en)
AU (1)	AU649245B2 (en)
CA (1)	CA2039458A1 (en)
IL (1)	IL97641A0 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6552170B1 (en)	1990-04-06	2003-04-22	Amgen Inc.	PEGylation reagents and compounds formed therewith
JP3623501B2 (en) *	1991-10-31	2005-02-23	ザビクトリアユニバーシティオブマンチェスター	Treatment of neurological conditions with interleukin-1 inhibitory compounds
IT1270662B (en) *	1994-10-13	1997-05-07	Applied Research Systems	INTERLEUCHIN-1 ANTAGONIST
US5837495A (en) *	1994-10-13	1998-11-17	Applied Research Systems Ars Holding N.V.	DNA encoding interleukin-1 antagonist
ES2224160T3 (en) *	1995-04-07	2005-03-01	Teijin Limited	PROTECTIVE AGENT FOR ORGAN OR FABRIC.
IL125552A0 (en) *	1996-02-09	1999-03-12	Amgen Inc	Composition comprising interleukin-1 inhibitor and controlled release polymer
DE69738948D1 (en) *	1996-12-06	2008-10-09	Amgen Inc	IL-1 inhibitor in combination therapy for the treatment of IL-1 mediated diseases
US6294170B1 (en)	1997-08-08	2001-09-25	Amgen Inc.	Composition and method for treating inflammatory diseases
US8106098B2 (en)	1999-08-09	2012-01-31	The General Hospital Corporation	Protein conjugates with a water-soluble biocompatible, biodegradable polymer
EP2241328A1 (en) *	2000-05-12	2010-10-20	Immunex Corporation	Interleukin-1 inhibitors in the treatment of diseases
PT2087908T (en)	2001-06-26	2018-07-16	Amgen Inc	Antibodies to opgl
NZ605429A (en)	2002-09-06	2014-08-29	Amgen Inc	Therapeutic human anti-il-1r1 monoclonal antibody
PE20070684A1 (en)	2005-11-14	2007-08-06	Amgen Inc	RANKL-PTH / PTHrP ANTIBODY CHEMERICAL MOLECULES
KR100733025B1 (en) *	2006-05-24	2007-06-28	윤인석	A structure of bottle cap with safety
CN112142855A (en)	2012-05-18	2020-12-29	爱德迪安（北京）生物技术有限公司	Protein for diabetes treatment, protein conjugate and application thereof
US20160000936A1 (en)	2014-06-10	2016-01-07	Abbvie Inc.	Biomarkers for inflammatory disease and methods of using same
US20210236599A1 (en)	2018-08-13	2021-08-05	Iltoo Pharma	Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH02223597A (en) *	1988-10-24	1990-09-05	Otsuka Pharmaceut Co Ltd	Interleukin-1beta derivative
JP2863265B2 (en) *	1989-05-19	1999-03-03	ハダサメディカルオーガニゼーション	Interleukin 1 inhibitor

1991
- 1991-03-20 AU AU73636/91A patent/AU649245B2/en not_active Expired
- 1991-03-21 IL IL97641A patent/IL97641A0/en not_active IP Right Cessation
- 1991-03-28 CA CA002039458A patent/CA2039458A1/en not_active Abandoned
- 1991-04-01 JP JP3068640A patent/JP2609485B2/en not_active Expired - Lifetime
- 1991-04-02 KR KR1019910005277A patent/KR920005691A/en not_active Application Discontinuation
1996
- 1996-06-26 JP JP8166399A patent/JP2942196B2/en not_active Expired - Lifetime
1999
- 1999-01-18 JP JP11009712A patent/JPH11269089A/en active Pending

Also Published As

Publication number	Publication date
JP2609485B2 (en)	1997-05-14
AU7363691A (en)	1991-10-03
JP2942196B2 (en)	1999-08-30
AU649245B2 (en)	1994-05-19
JPH09118632A (en)	1997-05-06
KR920005691A (en)	1992-04-03
CA2039458A1 (en)	1991-10-03
JPH11269089A (en)	1999-10-05
JPH05112462A (en)	1993-05-07

Legal Events

Date	Code	Title
1999-04-11	FF	Patent granted
1999-06-20	FF	Patent granted
1999-12-22	HC	Change of name of proprietor(s)
2000-02-17	KB	Patent renewed
2001-06-14	KB	Patent renewed
2005-05-17	KB	Patent renewed
2009-08-31	KB	Patent renewed
2011-12-29	EXP	Patent expired

Publication	Publication Date	Title
HU907339D0 (en)	1991-08-28	Process for treating diseases
EP0727998A4 (en)	1997-03-19	Oxazoles for treating cytokine mediated diseases
AU616091B2 (en)	1991-10-17	Treatment process
AU2293888A (en)	1989-04-06	Dosage form for treating cardiovascular diseases
IL97641A0 (en)	1992-06-21	Methods for treating interleukin-1 mediated diseases
GB2233996B (en)	1993-07-14	Well treatment method
SG14495G (en)	1995-06-16	Ocular treatment apparatus
EP0444156A4 (en)	1992-12-09	Method for treating vascular diseases
GB2225570B (en)	1992-08-19	Continuous treatment process
ZA911981B (en)	1992-03-25	Methods for treating interleukin-1 mediated diseases
GB9015095D0 (en)	1990-08-29	Therapeutic method
AU6034990A (en)	1991-02-22	Water treatment apparatus
GB2243602B (en)	1993-05-05	Treatment process
GB2241958B (en)	1993-08-25	Treatment process
RU1785687C (en)	1993-01-07	Method for glossalgia treatment
IE890034L (en)	1989-07-11	Treating hemalologic diseases
GB8912239D0 (en)	1989-07-12	Treating method
GB2242424B (en)	1993-05-05	Treatment process
GB9025594D0 (en)	1991-01-09	Treatment method
ZA919247B (en)	1992-10-28	Treatment method
GB9025596D0 (en)	1991-01-09	Treatment method
GB9025595D0 (en)	1991-01-09	Treatment method
GB9025593D0 (en)	1991-01-09	Treatment method
GB9026346D0 (en)	1991-01-23	Therapeutic method
GB8927300D0 (en)	1990-01-31	Therapeutic method